We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App

New Reagent Aids in Diagnosis of Connective Tissue Disease in Hard-to-Detect Autoimmune Conditions

By LabMedica International staff writers
Posted on 19 Oct 2023
Print article
Image: The Aptiva Connective Tissue Disease Essential reagent has received US FDA 510(K) clearance (Photo courtesy of Werfen)
Image: The Aptiva Connective Tissue Disease Essential reagent has received US FDA 510(K) clearance (Photo courtesy of Werfen)

The increasing incidence of autoimmune diseases like rheumatoid arthritis, lupus, and multiple sclerosis has created great demand for accurate and reliable diagnostic methods. As patients become more knowledgeable about the symptoms and risks of these diseases, they are seeking quicker testing solutions for early detection and management. Reagents and consumables are a key component in the diagnostic process of autoimmune disorders. Now, a new reagent can aid in the diagnosis of connective tissue disease in hard-to-diagnose autoimmune diseases, thus speeding up diagnosis and enhancing patient outcomes.

Werfen (Barcelona, Spain) has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Aptiva Connective Tissue Disease (CTD) Essential reagent. This product complements the company's already FDA-approved Aptiva Celiac Disease reagent. Apart from CTD and Celiac Disease tests, Aptiva is working on diagnostics for other autoimmune conditions and has more than 60 analytes at different stages of advanced development. These analytes have the capability to shorten the diagnostic time for autoimmune diseases and contribute to more effective patient care.

The Aptiva system is a fully automated multi-analyte platform that marks the next generation of high-throughput multi-analyte systems for clinical autoimmune labs. This system employs particle-based multi-analyte technology (PMAT) which simultaneously processes multiple analytes using a single patient sample. Thanks to PMAT, the Aptiva CTD Essential reagent can yield of up to 600 results per hour and enable labs to handle their testing volumes with minimal hands-on time.

"Aptiva CTD Essential with its unique biomarker composition and high level of analytical and clinical performance represents a breakthrough that fundamentally enhances the utility of diagnostic testing in the autoimmune laboratory," said Michael Mahler, PhD, Vice President of Research and Business Development at Werfen. "We are excited to bring this latest expansion of the Aptiva reagent menu to the US market, resulting in advanced patient care."

Related Links:

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
Spinal Fluid Cell Count Control
POCT Fluorescent Immunoassay Analyzer
25-OH Vitamin D3/D2 ELISA Test
25-OH Vitamin D3/D2

Print article


Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: Scientists have discovered a new amyloid-forming protein in neurodegenerative disease (Photo courtesy of 123RF)

Discovery of Rogue Protein Paves Way for Diagnostic Test to Detect Early-Onset Dementia

Neurodegenerative disorders are often marked by the buildup of amyloid filament inclusions of specific proteins in the brain. These proteins are critical in diagnosing and treating the associated diseases.... Read more


view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more


view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more


view channel
Image: Three examples of Anthrobots with hair-like cilia in yellow (Photo courtesy of Gizem Gumuskaya)

Tiny Biological Robot Healers Built From Human Cells Could Recognize Bacteria

In a pioneering study, researchers have developed microscopic biological robots, termed Anthrobots, from human tracheal cells. These tiny robots, varying in size from the width of a human hair to the tip... Read more


view channel
Image: Made-to-order diagnostic tests may soon be on the horizon (Photo courtesy of McGill University)

Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible

Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read more


view channel
Image: Covaris offers instruments, consumables, and reagents for high-throughput genomic and proteomic analysis (Photo courtesy of Covaris)

PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform

PerkinElmer, Inc. (Waltham, MA, USA), a global analytical services and solutions provider has acquired Covaris (Woburn, MA, USA), a developer of solutions to empower life science innovations.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.